GELITA AG

About GELITA AG

GELITA is one of the leading companies for manufacturing and marketing collagen proteins. Coordinated from headquarters in Germany, GELITA provides customers around the world with products of the highest standard, comprehensive technical expertise and sophisticated solutions. Within its range of collagen proteins, GELITA supplies collagen peptides with proven body-stimulating capabilities as well as tailor-made gelatins for a variety of applications: Softgel- and Hardcapsules, Tablets, Fortified Gummies, Vaccines and Medical Devices. 

  • DE
  • 2023
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Excipients Manufacturer
Contact info

Products from GELITA AG (3)

  • DELASOL®

    Product DELASOL®

    DELASOL® is a gelatin product for the one-step production of truly enteric capsules that open in the intestine (instead of the stomach, as with traditional gelatine capsules).
    Most enteric delivery systems are produced by applying an acid-insoluble coating to freshly produced soft cap...
  • EASYSEAL®

    Product EASYSEAL®

    A new era of softgel production has begun. EASYSEAL® is a unique solution that enables manufacturers to optimize their process in one easy step. By switching to new EASYSEAL® gelatin, you can enjoy significant reductions in leakers, lower processing costs and higher quality end products.

    S...
  • RXL® Ultra

    Product RXL® Ultra

    With RXL® Ultra, GELITA re-focusses on an established, but un-noticed, solution to conquer crosslinking challenges. As part of the RXL® product portfolio, the modified gelatin RXL® Ultra is the benchmark in anti-crosslinking performance for gelatin based excipients. While maintaining the known benefits...

GELITA AG Resources (1)

  • Video Heavy Crosslinking Due to Novel Plant Extracts – Challenge Accepted With Rxl® Ultra

    Existing and upcoming trends for plant-based extracts represent a challenge for softgel manufacturers – as potential extreme crosslinking components. With RXL® Ultra, GELITA re-focusses on an established, but hidden/un-noticed, solution to conquer these crosslinking challenges. As part of the RXL®-product family, the modified gelatin RXL® Ultra is the benchmark in anti-crosslinking performance for gelatin based excipients. While maintaining the known benefits in softgel production for gelatin, it provides ultimate potential to solve even extreme crosslinking and – in the end – deliver reliable products to the consumer. This session will also provide insights on the regulatory background for RXL® Ultra and how to overcome challenges when used as capsule material.